NASDAQ
Bolt Biotherapeutics, Inc. (BOLT) has a fcf yield of -390.30% as of Monday, August 3, 2026. This represents a 136.96% decrease compared to its 12-month average of -164.71%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.